| Revenue growth | 19% YoY for FY26 |
|---|---|
| Margins | Gross margin improved to 31%; EBITDA margin slightly down to 10.4% |
| Demand visibility | Expanding domestic B2C and new export territories |
| Management confidence | High; focusing on integrated agri-solutions platform |
Growth
FY26 Revenue grew 19% to ₹7,046 Mn; EBITDA up 15% to ₹740 Mn; PAT surged 27% to ₹400 Mn.
Outlook
Focus on high-margin products, scaling biologicals, global expansion (Brazil/Africa), and improving capacity utilization from current 52%.
Risks
Potential impact from global economic conditions, industry competition, and dependence on agri-seasonal cycles.
Earnings Call filed with BSE, NSE: IGCL. Summary written with AI assistance from the document.
Indogulf Cropsciences Ltd: key numbers
- Share price
- ₹63.10
- Market cap
- ₹398.9 Cr
- Revenue (annual)
- ₹704.6 Cr
- Net profit (annual)
- ₹40.03 Cr
- P/E (TTM)
- 9.2×Sector 35.5×
- Promoter holding
- 69.05%+0.00% QoQ
- FII holding
- 0.07%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Indogulf Cropsciences Ltd
All →Indogulf Cropsciences Earnings Call Transcript: Key Takeaways
Q2 revenue +3% to ₹255.8 Cr; EBITDA +27%, margin 16% (13%) on mix and cost cuts. H1 revenue -3%, negative operating cash flow, inventory elevated.
Indogulf Cropsciences Results Update
Indogulf Cropsciences reported Q2 FY27 EBITDA of ₹41 Cr (up 27%) and PAT of ₹26 Cr (up 24%). Margin expanded 300 bps to 16% on favourable product mix.
Indogulf Cropsciences Other Announcement
Indogulf Cropsciences filed its Monitoring Agency Report for the quarter ended September 30, 2026, covering IPO proceeds of Rs 200 crore. The report states no deviation from the objects of the issue.
Indogulf Cropsciences Investor Presentation: Key Takeaways
Q2 FY27 revenue up 3% YoY to INR 2,558 Mn; EBITDA up 27% to 406 Mn (15.9% margin); PAT up 24% to 257 Mn. H1 revenue down 3%.
Indogulf Cropsciences Q2 FY27 Results: Net Profit ₹25.7 Cr, Up 24.2% YoY
Indogulf Cropsciences Ltd reported revenue from operations of ₹255.8 Cr (+3.0% YoY) and net profit of ₹25.7 Cr (+24.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹25.7 Cr · +24.2% YoY
Indogulf Cropsciences Board Meeting Date
Indogulf Cropsciences will hold a board meeting on 2 November 2026 to consider unaudited standalone and consolidated results for the quarter ended September 2026. The trading window closes from 1 October 2026.